A compound of formula (I) or formula (Ia)
Wherein R
1
, R
a
, R
2
, X, R
3
, Y
1
, Y
2
, A, B and C are as defined herein. Also, pharmaceutical compositions comprising such compounds and excipients, methods of treating bacterial infections comprising administering such compounds, methods for making such compounds and hydrates of such compounds.
PHENANTHRENEQUINONE COMPOUND, ELECTRODE ACTIVE MATERIAL, AND POWER STORAGE DEVICE
申请人:Ohtsuka Yu
公开号:US20100047688A1
公开(公告)日:2010-02-25
Disclosed is a novel organic compound synthesized by oligomerizing or polymerizing a specific quinone compound having two quinone groups at the ortho position and having a property such that the electron transfer occurs associated with a reversible redox reaction, the organic compound being insoluble in an organic solvent and having a high energy density, and thus being useful as an electrode active material for a power storage device. Using this organic compound as an electrode active material can improve the energy density, reduce the weight and size, and improve the functionality of the power storage device.
The present invention relates to hepatitis C virus (HCV) NS3 protease inhibitors containing a spirocyclic moeity, uses of such compounds, and synthesis of such compounds.
本发明涉及含有螺环结构的丙肝病毒(HCV)NS3蛋白酶抑制剂,以及这些化合物的用途和合成方法。
Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such
申请人:Southern Research Institute
公开号:US10953017B2
公开(公告)日:2021-03-23
Methods for enhancing memory and/or learning and prevent neurodegeneration by administration of certain heterocyclic and aromatic compounds are described. The methods are particularly useful for treating patients suffering from a neurodegenerative disease such as (without limitation) Alzheimer's, Parkinsons's, Lou Gehrig's (ALS) disease or memory or learning impairment. A neuronal human cell-based assay that assess NF-kB gene up-regulation using a luciferase reporter is also provided that screens for compounds useful in methods for enhancing memory or learning.
Inhibitors of mechanotransduction to treat pain and modulate touch perception
申请人:Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft
公开号:US11384071B2
公开(公告)日:2022-07-12
Chemical compounds that are useful as inhibitors of mechanotransduction in the treatment of pain and modulation of touch perception and topical administration of the compounds described herein in the treatment of pain and modulation of touch perception.